IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Raptor Pharmaceutical Corp

CUSIP: 75382F906 | 4 institutional holders

Quarters

Q3 2016Q2 2016Q1 2016Q4 2015Q3 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile